14 Sept 2026, 10:36
Company AdministrationMS
BITBIOTRON LIMITED
Announcement history available from 1 August 2025
Fromto
4 Sept 2026, 11:08
Securities Administration—
3 Sept 2026, 10:20
Presentations—
27 Aug 2026, 13:35
Company Administration—
27 Aug 2026, 13:33
Company Administration—
27 Aug 2026, 13:21
Financial ResultsMS
18 Aug 2026, 13:40
Substantial Holders—
17 Aug 2026, 13:44
Company Update—
21 July 2026, 10:46
Quarterly ReportsMS
15 July 2026, 16:48
Director Interests—
13 July 2026, 11:30
Securities Administration—
13 July 2026, 11:24
Mergers & AcquisitionsMS
17 June 2026, 12:51
Securities Administration—
4 June 2026, 09:13
Periodic ReportsMS
29 May 2026, 16:12
Securities Administration—
15 May 2026, 10:24
Director Interests—
29 Apr 2026, 10:01
Quarterly ReportsMS
10 Apr 2026, 09:30
Company Administration—
30 Mar 2026, 15:22
Company Administration—
19 Mar 2026, 11:25
Presentations—
18 Mar 2026, 08:56
Company UpdateMS
26 Feb 2026, 17:00
Financial ResultsMS
6 Feb 2026, 12:51
Company Administration—
30 Jan 2026, 10:22
Securities Administration—
30 Jan 2026, 10:08
Securities Administration—
30 Jan 2026, 10:05
Capital RaisingMS
29 Jan 2026, 09:18
Quarterly ReportsMS
12 Jan 2026, 13:53
Substantial Holders—
23 Dec 2025, 15:31
Director Interests—
23 Dec 2025, 15:19
Securities Administration—
23 Dec 2025, 15:18
Securities Administration—
23 Dec 2025, 10:40
Company Administration—
22 Dec 2025, 08:34
ReinstatementMS
19 Dec 2025, 17:10
Securities Administration—
19 Dec 2025, 11:30
Securities Administration—
19 Dec 2025, 11:29
Securities Administration—
19 Dec 2025, 11:19
Capital RaisingMS
15 Dec 2025, 09:14
Trading Halt / SuspensionMS
10 Dec 2025, 17:53
Securities Administration—
10 Dec 2025, 17:48
Securities Administration—
10 Dec 2025, 17:44
Securities Administration—
10 Dec 2025, 17:39
Mergers & Acquisitions—
2 Dec 2025, 17:04
Capital Raising—
2 Dec 2025, 15:17
Securities Administration—
2 Dec 2025, 14:58
Securities Administration—
2 Dec 2025, 14:38
Securities Administration—
26 Nov 2025, 12:29
Capital Raising—
19 Nov 2025, 13:17
Securities Administration—
18 Nov 2025, 11:16
Capital RaisingMS
17 Nov 2025, 18:51
Meetings & Governance—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 14 Sept 2026, 10:36 | Resignation of Managing Director and Appendix 3Z | Company Administration | MS | 02010, 12019 | |
| 4 Sept 2026, 11:08 | Change of Share Registry | Securities Administration | — | 12004 | |
| 3 Sept 2026, 10:20 | Investor Presentation | Presentations | — | 03026 | |
| 27 Aug 2026, 13:35 | Appendix 4G | Company Administration | — | 03025 | |
| 27 Aug 2026, 13:33 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 27 Aug 2026, 13:21 | Full Year Statutory Accounts and Appendix 4E | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 18 Aug 2026, 13:40 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 Aug 2026, 13:44 | HBV Treatment to Progress Towards Human Trials | Company Update | — | 11001 | |
| 21 July 2026, 10:46 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 15 July 2026, 16:48 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 13 July 2026, 11:30 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 13 July 2026, 11:24 | Sedarex First Milestone Met | Mergers & Acquisitions | MS | 07001, 11001 | |
| 17 June 2026, 12:51 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 4 June 2026, 09:13 | $525K R&D Rebate Received | Periodic Reports | MS | 03014 | |
| 29 May 2026, 16:12 | Release From Voluntary Escrow | Securities Administration | — | 06009 | |
| 15 May 2026, 10:24 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 29 Apr 2026, 10:01 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 10 Apr 2026, 09:30 | Director Retirement | Company Administration | — | 12001, 12017 | |
| 30 Mar 2026, 15:22 | Director Appointment Graeme Wald & Appendix 3X | Company Administration | — | 02008, 12001 | |
| 19 Mar 2026, 11:25 | Investor Update | Presentations | — | 03026 | |
| 18 Mar 2026, 08:56 | Hepatitis B Virus Program Update | Company Update | MS | 11001 | |
| 26 Feb 2026, 17:00 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 6 Feb 2026, 12:51 | Final Director's Interest Notice | Company Administration | — | 02010, 12001 | |
| 30 Jan 2026, 10:22 | Supplementary Prospectus | Securities Administration | — | 06010 | |
| 30 Jan 2026, 10:08 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 30 Jan 2026, 10:05 | Successful Issue of the Entitlement Offer Shortfall | Capital Raising | MS | 06008 | |
| 29 Jan 2026, 09:18 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 12 Jan 2026, 13:53 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 23 Dec 2025, 15:31 | Change of Director's Interest Notice x 4 | Director Interests | — | 02009 | |
| 23 Dec 2025, 15:19 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 23 Dec 2025, 15:18 | Cancel - Notification regarding unquoted securities - BIT | Securities Administration | — | 06021 | |
| 23 Dec 2025, 10:40 | Director Appointment Dr Paul Kasian & Appendix 3X | Company Administration | — | 02008, 12001 | |
| 22 Dec 2025, 08:34 | Security Class Reinstatement to Quotation - BITO | Reinstatement | MS | 09002 | |
| 19 Dec 2025, 17:10 | Notification regarding unquoted securities - BIT | Securities Administration | — | 06021 | |
| 19 Dec 2025, 11:30 | Top 20 optionholders and distribution | Securities Administration | — | 03002, 06009 | |
| 19 Dec 2025, 11:29 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 19 Dec 2025, 11:19 | Rights Issue Close | Capital Raising | MS | 06008 | |
| 15 Dec 2025, 09:14 | Security Class Suspension from Quotation - BITO | Trading Halt / Suspension | MS | 09001 | |
| 10 Dec 2025, 17:53 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 10 Dec 2025, 17:48 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 10 Dec 2025, 17:44 | Notification regarding unquoted securities - BIT | Securities Administration | — | 06021 | |
| 10 Dec 2025, 17:39 | Completion of acquisition of Sedarex Limited | Mergers & Acquisitions | — | 06009, 07001, 11001 | |
| 2 Dec 2025, 17:04 | Completion of Tranche 2 of Placement | Capital Raising | — | 06003 | |
| 2 Dec 2025, 15:17 | Notification regarding unquoted securities - BIT | Securities Administration | — | 06021 | |
| 2 Dec 2025, 14:58 | Notification regarding unquoted securities - BIT | Securities Administration | — | 06021 | |
| 2 Dec 2025, 14:38 | Application for quotation of securities - BIT | Securities Administration | — | 06020 | |
| 26 Nov 2025, 12:29 | Dispatch of Rights Issue Offer documents | Capital Raising | — | 06008, 14001 | |
| 19 Nov 2025, 13:17 | Rounding of fractions of attaching options | Securities Administration | — | 06009 | |
| 18 Nov 2025, 11:16 | Non-Renounceable rights Issue Prospectus | Capital Raising | MS | 06008, 06010 | |
| 17 Nov 2025, 18:51 | Results of Meeting | Meetings & Governance | — | 08003 |
1–50 of 77
1 / 2